Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01353976 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis
A Phase 3 study, sponsored by AmDerma.
- Completed
- Registry status
- Phase 3
- Development phase
- 264
- Enrollment target
NCT01353976: Completed Phase 3 study, sponsored by AmDerma.
NCT01353976 is a Phase 3 study that has completed, run by AmDerma. The registered enrollment target is 264 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01353976, a Phase 3 study, has completed, sponsored by AmDerma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 264 participants
- Enrollment target
Study Summary
This is a study of the safety and efficacy of topical Econazole Nitrate Foam 1% and the foam vehicle in subjects with interdigital tinea pedis (athlete's foot between the toes). This is a 6 week study which has a 4 week treatment period and a 2 week follow-up evaluation.
Primary Outcome
Complete Cure is defined as a negative KOH and negative fungal culture and no evidence of clinical disease as indicated by scores of 0 (none) for each sign and symptom at Day 43.
Interventions
- DRUG Econazole Nitrate Foam 1%
- OTHER Vehicle Foam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 264 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-08 |
| Phase | Phase 3 |
What the finished NCT01353976 record still lists
NCT01353976 is an interventional study that assigns participants to a tested intervention. The registered 264 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 2 interventions - of which Econazole Nitrate Foam 1% is the first listed.
NCT01353976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01353976 about?
NCT01353976 is a clinical study titled "Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis". This is a study of the safety and efficacy of topical Econazole Nitrate Foam 1% and the foam vehicle in subjects with interdigital tinea pedis (athlete's foot between the toes). This is a 6 week study which has a 4 week treatment period and a 2 week follow-up evaluation.
What is the current status of trial NCT01353976?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 264 participants. The study started on 2011-05. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01353976?
The interventions under investigation include: Econazole Nitrate Foam 1% (DRUG), Vehicle Foam (OTHER).
Who is sponsoring clinical trial NCT01353976?
This trial is sponsored by AmDerma, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01353976's enrollment target sits among peer trials
264 1225th of 2000 higher than 773 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04101669 · 264 participants · NA
RESET System Pivotal Trial (Rev F)
- NCT04295863 · 264 participants · Phase 1
Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
- NCT05220202 · 264 participants · NA
MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression
- NCT05473013 · 264 participants · NA
Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia